RevMAb

Recombinant monoclonal antibodies

RevMAb Biosciences USA is a biotechnology company focused on the development of recombinant monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. The recombinant antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology. This revolutionary method has successfully been applied to develop high quality recombinant rabbit and goat monoclonal antibodies.

 

Product Range:

  • anti-Histone antibodies / Histone modifications
  • Mutation specific antibodies against Histone mutations and other point mutations of other proteins
  • Mutations specific antibodies for Immunohistochemistry / IHC
  • Antibodies for immunohistochemistry
  • Pan-Protein modification antibodies
  • Secondary antibodies
  • Matched pair antibodies for the detection of human Ig classes and IgG Subclasses

https://www.revmab.com/

Show Product

Other Partners

magtivio

magtivio

Magnetic Beads for Separation of Biomolecules

AlphaTecSystems

AlphaTecSystems

Mycobacteriology and parasitology clinical diagnostics

ALPCO

ALPCO

Innovative molecular and immunodiagnostic products

Cyagen Biosciences Inc.

Cyagen Biosciences I...

Stem Cell Products

TNC Bio

TNC Bio

XerumFree – Defined Cell Culture